1. The Progress of Experiment: Science and Therapeutic Reform in the United States, 1900–1990;Harry Marks,1997
2. Pharmacovigilance and the missing denominator: the changing context of pharmaceutical risk mitigation;Daemmrich;Pharm. Hist.,2007
3. Frances Kelsey, Autobiographical Reflections, p. 71. FDA History Office.
4. Development of drug law, regulations and guidance in the U.S.;Temple,1994
5. Current definitions of phases of investigation and the role of the FDA in the conduct of clinical trials;Temple;Am. Heart J.,2000